Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Similar Items

• Hypopharyngeal Dose is Associated with Severe Late Toxicity in Locally Advanced Head and Neck Cancer: An RTOG Analysis
  od: Machtay, Mitchell, i dr.
  Izdano: (2012)
• Long-Term Results of Concomitant Boost Radiation plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: a Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)
  od: Garden, Adam S., i dr.
  Izdano: (2008)
• Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
  od: Rosenthal, David I., i dr.
  Izdano: (2009)
• RTOG 90-03: Legacies of a Landmark Trial
  od: Trotti, Andy, i dr.
  Izdano: (2014)
• The Impact of Gender, Partner Status, and Race on Locoregional Failure and Overall Survival in Head and Neck Cancer Patients in Three Radiation Therapy Oncology Group (RTOG) Trials
  od: Dilling, Thomas J., i dr.
  Izdano: (2011)